A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]
, 2012 Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru +4 more
core +3 more sources
Stereotactic Radiosurgery Practice Patterns for Brain Metastases in the United States: A National Survey [PDF]
, 2018 Background: Stereotactic radiosurgery (SRS) has emerged as an important modality for the treatment of intracranial metastases. There are currently few established guidelines delineating indications for SRS use and fewer still regarding plan evaluation in
Bhamidipati, Deepak +7 more
core +2 more sources
Interobserver Reliability in Describing Radiographic Lung Changes After Stereotactic Body Radiation Therapy [PDF]
, 2018 Purpose Radiographic lung changes after stereotactic body radiation therapy (SBRT) vary widely between patients. Standardized descriptions of acute (≤6 months after treatment) and late (\u3e6 months after treatment) benign lung changes have been proposed
Hugo, Geoffrey D. +6 more
core +3 more sources
The role of stereotactic radiosurgery in the multimodal management of growth hormone–secreting pituitary adenomas [PDF]
, 2010 Growth hormone (GH)–secreting pituitary adenomas represent a common source of GH excess in patients with acromegaly. Whereas surgical extirpation of the culprit lesion is considered first-line treatment, as many as 19% of patients develop recurrent ...
Liu, Charles Y. +2 more
core +1 more source
Anales del Sistema Sanitario de Navarra, 2020 The constant advances in the field of lung cancer immunotherapy have recently reached the treatment of locally advanced disease with the approval of durvalumab after concurrent chemoradiation.
M. Rico +5 more
doaj +1 more source
Stereotactic body radiation therapy for inoperable localized kidney cancer
Сибирский онкологический журнал, 2023 Purpose of the study: to evaluate the overall survival and local control in patients with inoperable kidney cancer treated with stereotactic body radiotherapy (SBRT).Material and Methods. From 2011 to 2021, 42 patients with histologically verified kidney
Zh. E. Sabelnikova +3 more
doaj +1 more source
Clinical and Translational Radiation Oncology, 2020 Background: There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation ...
John Nikitas +7 more
doaj +1 more source
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery [PDF]
Radiation Oncology Journal, 2015 Despite the increasing use of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS) in recent years, the biological base of these high-dose hypo-fractionated radiotherapy modalities has been elusive. Given that most human tumors contain radioresistant hypoxic tumor cells, the radiobiological principles for the conventional
Kim, Mi-Sook +7 more
openaire +2 more sources
A dose falloff gradient study in RapidArc planning of lung stereotactic body radiation therapy
Journal of Medical Physics, 2018 Introduction: Radiation Therapy Oncology Group (RTOG) report #0813 and 0915 recommends using D2cmand R50%as plan quality metrics for evaluation of normal tissue sparing in stereotactic body radiation therapy (SBRT) of lung lesion.
Ganesh Narayanasamy +5 more
doaj +1 more source
Rethinking the Role of Radiation Therapy in the Management of Epithelial Ovarian Cancer
Diagnostics, 2020 Radiation has been relegated to a palliative role in the management of epithelial ovarian cancer (EOC). Contemporary radiation techniques, including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image ...
Geraldine Jacobson +1 more
doaj +1 more source